Won Seog Kim

Research interests

Publications

• Genomic profiling for clinical decision making in lymphoid neoplasms

  Blood · 2022 · https://doi.org/10.1182/blood.2022015854

• Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32984-2

• Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-03987-2

• Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.73.3402

• Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.75.4648

• A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

  The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(15)00533-1

• Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis

  The Lancet Haematology · 2015 · https://doi.org/10.1016/s2352-3026(15)00002-2

• ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

  Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds517

• Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.8592

• The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

  Blood · 2007 · https://doi.org/10.1182/blood-2007-01-067769

• Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.04.1384

• An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach

  International Journal of Radiation Oncology*Biology*Physics · 2005 · https://doi.org/10.1016/j.ijrobp.2005.05.005

Current projects

No projects listed.